Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 55111-533

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55111-533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Divalproex Sodium Extended-release Tablets are a medication that comes in 250mg. The prescription information is written on the page with a warning to keep away from young children. There is also a reference to Dr. Reddy's pharmaceutical company, but no further details are provided.*

FDA Label Image

Container (Container)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This appears to be a table displaying a comparison of the improvement in CPS rate (which is not defined in the given text) between high dose and low dose formulations of delayed-release tablets of Divalproex Sodium. The table shows that the low dose formulation resulted in no change in CPS rate for 50% of patients, while the high dose formulation resulted in a reduction of CPS rate by 50%.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.